Vaccine News and Research

Latest Vaccine News and Research

A therapeutic interfering particle for SARS-CoV-2

Researchers report their attempt to engineer TIPs that can conditionally replicate with SARS-CoV-2, inhibit viral replication 10–100 fold, and exhibit R0>1.

16 Nov 2021

More than 13 million people in the UK received COVID-19 booster jabs

More than 13 million life-saving booster jabs have been given across the UK, marking another significant milestone in the phenomenal COVID-19 vaccination programme.

16 Nov 2021

Missouri’s thin dental safety net stretched amid Medicaid expansion

At the Access Family Care clinics in southwestern Missouri, the next available nonemergency dental appointment is next summer. Northwest Health Services, headquartered in St. Joseph, is booked through May. The wait is a little shorter at CareSTL Health in St. Louis — around six weeks.

16 Nov 2021

Modeling the role of antivirals in suppressing the COVID-19 pandemic

A new study used an agent-based mathematical model to evaluate potential population impact on the widespread use of antiviral treatment for reducing viral load and hospitalization risk.

16 Nov 2021

Impact of COVID-19 vaccination in the Norwegian population

Researchers quantified the general VE achieved in the population of Norway, with the realized mixture of vaccine types, current population characteristics, and epidemic trajectory and directly estimated VE across vaccine types and age groups.

16 Nov 2021

Myocarditis among Moderna COVID-19 vaccine recipients

A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.

16 Nov 2021

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

A new preprint reports a semi-quantitative test that can measure neutralizing antibodies to the SARS-CoV-2 pathogen at the point of care, using a finger stick or venipuncture blood.

16 Nov 2021

Thrombosis with thrombocytopenia syndrome rare but serious adverse event associated with Ad26.COV2.S vaccination

A recent study conducted in the United States has revealed that thrombosis with thrombocytopenia syndrome following adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccination is a rare event.

16 Nov 2021

Deficient spike-specific T cell responses and inability to neutralize SARS-CoV-2 variants 12 month post-infection

Researchers conducted a comprehensive, longitudinal, long-term immune study, including functional assays to assess immune fitness against antigenically different VoC. The study is currently available on the preprint server medRxiv* while awaiting peer review.

15 Nov 2021

Immune response elicited by SARS-CoV-2 vaccines in infliximab and vedolizumab-treated patients with IBD

A recent study evaluates the immune responses elicited by COVID-19 vaccines in infliximab- or vedolizumab-treated IBD patients.

15 Nov 2021

Study identifies a host factor that reflects different levels of inflammation within mild COVID-19 cases

A new study investigates serum from COVID-19 convalescents and uninfected individuals to determine the molecular mechanisms of host responses.

15 Nov 2021

Scientists develop a promising new approach to potentially treat Alzheimer's disease

A promising new approach to potentially treat Alzheimer's disease – and also vaccinate against it – has been developed by a team of UK and German scientists.

15 Nov 2021

Promising results from Phase II REGEN-COV study

Initial results of the REGEN-COV Phase II study are presented.

15 Nov 2021

Potential COVID-19 nasal spray vaccine shows promise in mice

A single sniff may one day be all it takes to immunize yourself against COVID-19.

15 Nov 2021

Long-term study begins to evaluate COVID-19's effects on the overall health of children

A large, long-term study of the impacts of COVID-19 on children has enrolled its first participant at the National Institutes of Health's Clinical Center in Bethesda, Maryland.

15 Nov 2021

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

A new study determines the safety of an additional vaccine among individuals who previously received two doses of mRNA-based COVID-19 vaccines.

15 Nov 2021

Benefits of vaccine mandates and vaccine passports for SARS-CoV-2

A new study has been published that evaluates the benefits of VMVP by estimating the benefits of vaccination and exclusion of unvaccinated people from different settings.

15 Nov 2021

Vaccination protects against COVID-19 related hospitalization in patients with and without comorbidity

Researchers from University Medical Centre Utrecht have been investigating the efficiency of vaccines against the alpha variant in the Netherlands.

15 Nov 2021

Mainstream media coverage of vaccines during COVID-19 pandemic

A recent study explores how vaccine coverage has come to the forefront of modern news media following the emergence of SARS-CoV-2.

15 Nov 2021

Public health strategies associated with reduced SARS-CoV-2 transmission in Switzerland

The current study attempts to estimate the quantitative effects of specific measures, using a combination of phylogenetic and phylodynamic approaches.

15 Nov 2021